• On November 24th, 2015, the Americas Health Foundation participated in the First International Forum on “the Challenges of Biosimilars” (Foro Internacional “El desafio de los biosimilares”) at the Centro de Convenciones 28 de Julio in Lima, Peru. The conference focused on the challenges associated with increasing access to biosimilars in both Peru and Latin America generally. The Forum was attended by local and international visitors, including health professionals, researchers, and representatives of patient associations, government agencies, and regulating bodies.
  • In response to a variety of needs represented by differing vaccination policies across Central America and the Caribbean, the AHF has convened a Central America (CAM) Dengue Task Force comprised of clinicians from Central America and the Caribbean who specialize in diagnosing and treating dengue. Given that dengue has a high impact on public health in the Region, it is necessary that epidemiological information from individual countries be collected and analyzed in order to develop the best strategy from vaccine implementation in the Region as a whole.
  • As a follow-up to the Dengue Task Force meeting, in regard to planning for country-specific outreach, AHF sponsored the participation of several Dengue Task Force members and a KOL in a 1.5 day Dengue Symposium, “Retos en la Prevención Y Control Del Dengue Avances Y Proyección de la EGI-Dengue en la Región de las Americas” organized with the Colombia Ministry of Health as part of  the larger XVI Congreso Colombiano de Parasitología Y Medicina Tropical 2015 held in Santa Marta, Colombia October 21 -22.
  • AHF organized the Roundtable Discussion on Decreasing the Burden of Influenza in Latin America in Rio de Janeiro, Brazil
  • The AHF convened a meeting of the Dengue Task Force in December to review its year-long activities, and with the recent development of Mexico becoming the first country in the region to register the dengue vaccine, plan additional activities to support continued education and advocate for the development of an effective dengue vaccination policy and support health authorities in the decision-making process for introducing and implementing the recently discovered dengue vaccine in 2016.
  • Following the summit convened by AHF that brought together representatives of 15-20 regional and national medical societies, primarily focused on pediatrics, infectious disease and immunology, the article produced at the conference, Reommendations on Increase Adult Vaccination in Latin America, was published in the December 2015 edition of Revista Panamericana de Infectología.  The recommendations were endorsed by 24 major Latin American medical societies.
  • The recently released WHO Proposed Addendum to Who TRS 987 Annex 4 – Guidelines on the quality, safety and efficacy of biotherapeutic protein products prepared by recombinant DNA technologies included as a reference an article developed during an AHF sponsored consensus conference: Recommendations for the Regulation of Biosimilars and their Implementation in Latin America. The article was originally published in the GaBI Journal.
  • Break Dengue is calling on citizens around the world to voice their concern about the growing social burden that represents dengue fever and help make it a public health priority. As global and regional health leaders meet to address urgent climate, health, and security issues threatening the world’s population, the Dengue Tribe campaign aims to collect the faces and voices of individuals and communities impacted by the disease to show these leaders it is time to take global collaborative actions to control dengue.
  • Americas Health Foundation representatives participated in the 2015 CONGRESO LATINOAMERICANO DE INFECTOLOGIA PEDIATRICA – SLIPE held in San Juan, Puerto Rico in June.